 | |
 | |
| Clinical data | |
|---|---|
| Trade names | Frazalon, Miotalon, Qu Zhi Shu |
| Other names | Androfurazanol; DH-245; Furazalon; Frazalon; Pirzalon; 17α-Methyl-5α-androsta[2,3-c]furazan-17β-ol; 17β-Hydroxy-17α-methyl-5α-androstano[2,3-c]-1',2',5'-oxadiazole; 17α-Methyl-5α-androstano[2,3-c][1,2,5]oxadiazol-17β-ol |
| Routes of administration | By mouth |
| Drug class | Androgen;Anabolic steroid |
| ATC code | |
| Legal status | |
| Legal status | |
| Pharmacokinetic data | |
| Eliminationhalf-life | 4 hours[citation needed] |
| Excretion | Urine |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| DrugBank |
|
| ChemSpider |
|
| UNII | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.013.621 |
| Chemical and physical data | |
| Formula | C20H30N2O2 |
| Molar mass | 330.472 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
 N Y (what is this?) (verify) | |
Furazabol (INNTooltip International Nonproprietary Name,JANTooltip Japanese Accepted Name) (brand namesFrazalon,Miotalon,Qu Zhi Shu), also known asandrofurazanol, is asynthetic,orally activeanabolic-androgenic steroid which has been marketed inJapan since 1969.[1][2][3][4] It is a17α-alkylatedderivative ofdihydrotestosterone (DHT) and is closely related structurally tostanozolol, differing from it only by having afurazanring system instead ofpyrazole.[5] Furazabol has a relatively high ratio ofanabolic toandrogenic activity.[4] As with other 17α-alkylated AAS, it may have a risk ofhepatotoxicity.[6] The drug has been described as anantihyperlipidemic and is claimed to be useful in the treatment ofatherosclerosis andhypercholesterolemia,[5] but according to William Llewellyn, such properties of furazabol are a myth.[7]
Previously a relatively unknown drug to North American athletes, Furazabol gained notoriety in theCommission of Inquiry into the Use of Drugs and Banned Practices Intended to Increase Athletic Performance (known colloquially as theDubin inquiry). After winning the 100m gold at the1988 Summer Olympics in Seoul, Canadian sprinterBen Johnson tested positive for the anabolic steroidStanozolol, was later stripped of his gold medal, and banned from competition for two years.[8] Johnson initially denied the allegations, asserting he had never taken banned substances. He later claimed the positive finding was the result of sabotage, and that he had actually taken Furazabol, which at the time could not be detected by theGas Chromatography-Mass Spectrometry assay used to analyze samples at the Games. Contrariwise, Stanozolol had been widely used in elite athlete circles since the 1970s, and as of 1988, could be reliably identified by conventional testing procedures.[9]
Testifying before the Dubin Inquiry, Johnson's physicianGeorge "Jamie" Astaphan claimed that he had been administering Furazabol (which he termed Estragol) to Johnson since the mid-1980s, and that Johnson likely self-administered Stanozolol within a month of the Games opening in Seoul.
In later testimony, Johnson's training mateAngella Issajenko told the Commission that she too had obtained Furazabol from Astaphan, or so she thought. The former-Canadian record holder revealed that, after Johnson's positive test, she had an analysis done on a leftover vial of what she thought contained Furazabol, and was informed it was identified as Stanozolol. Issajenko, and later the Commission's Chief Justice Charles Dubin, concluded Astaphan had been peddling Stanozolol to Johnson, Issajenko, and other Canadian team members all along, and that Furazabol was either a figment of his imagination, or an outright lie.[10]